logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Jerome Stevens Pharmaceuticals acquires Thyquidity®

Apr 02, 2025•9 months ago

Acquiring Company

Jerome Stevens Pharmaceuticals

Acquired Company

Azurity Pharmaceuticals

BohemiaWoburnManufacturingPharmaceuticalMedicalBiotechnologyHealth CareManufacturing

Description

Jerome Stevens Pharmaceuticals, Inc. has completed the acquisition of Thyquidity® from Azurity Pharmaceuticals, Inc. This deal enhances Jerome Stevens' endocrine portfolio and product pipeline. Thyquidity® will continue to be available for current and new patients through collaboration with Oliva Therapeutics.

Company Information

Company

Jerome Stevens Pharmaceuticals

Location

Bohemia, New York, United States

About

Jerome Stevens Pharmaceuticals, Inc. is a family owned and operated pharmaceutical manufacturer and packager of prescription tablet and capsule formulations. Operating exclusively in the United States, JSP continues to produce high quality and reliably supplied products while maintaining the same consistency that has been a staple of its history. The extreme pride and satisfaction in the quality of the products we make is the driving force behind this growing company.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed